IBM Israel Files $51 Million Countersuit Against Israel Chemicals
In December, the Israel-based chemical company sued IBM for $300 million, claiming the computing company was responsible for the failure of a 2012 project ICL had commissioned from it
Lital Dobrovitsky | 13:23 05.03.2019
Three months after being sued for NIS 1.1 billion (approximately $300 million) in damages by Israel Chemicals Ltd. (ICL), IBM Israel has filed a NIS 185 million (approximately $51 million) countersuit Monday. In its filings to a Tel Aviv district court, which were reviewed by Calcalist, IBM claims ICL did not pay for services provided by IBM and did not act in good faith. ICL filed a lawsuit over a 2012 project it commissioned from IBM to integrate a number of information systems used at the time by ICL's subsidiaries into one system. ICL claimed that every stage of the project had been unsuccessful and that IBM failed to meet the agreed upon schedule and costs. In 2016, ICL terminated the project after having spent almost $300 million on it—$100 million as payments to IBM, according to the company’s court filings.